scorecard

You Searched For "bharat biotech s covaxin" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…

PTI   


Business Insider Latest Story Image
2 mins read

Health Ministry rejects claim 'Covaxin was rushed due to political pressure'

The Union Health Ministry on Thursday rejected media reports that Covaxin manufacturer Bharat Biote…

Business Insider Latest Story Image
1 min read

Germany to recognise Bharat Biotech’s 'Covaxin' from June 1

In a tweet, Lindner said, Very happy that GER government just decided to recognize WHO-listed Covax…

Business Insider Latest Story Image
1 min read

DCGI gives nod to Bharat Biotech's Covaxin for 6-12 age group in India

The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event w…

Business Insider Latest Story Image
1 min read

DCGI grants regular market approval for Covishield, Covaxin with conditions

In a subsequent tweet, the health minister said, "The conditions include supply for programm…

Business Insider Latest Story Image
2 mins read

Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD

"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…

PTI   


Business Insider Latest Story Image
3 mins read

Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study

The results of an interim study recently published in The Lancet showed that two doses of Covaxi…

PTI   


Business Insider Latest Story Image
2 mins read

Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years

According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…

Business Insider Latest Story Image
1 min read

Study shows booster dose of Covaxin has neutralising effect on Omicron, Delta variants, says Bharat Biotech

The study conducted at Emory University demonstrated that subjects who received a booster dose o…

PTI   


Business Insider Latest Story Image
2 mins read

WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait

The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…

Business Insider Latest Story Image
1 min read

Brazil suspends Covaxin trials, weeks after graft allegations surfaced

The termination of the pact comes after the deal with the Brazilian government for supply of 20 …

PTI   


Business Insider Latest Story Image
1 min read

WHO may approve Bharat Biotech's Covaxin 'within 24 hours' for emergency use, according to media reports

"If all is in place and all goes well and if the committee is satisfied, we would expect a recom…

Business Insider Latest Story Image
3 mins read

India's Covaxin 77.8% effective for COVID-19, says Lancet Report

A"The efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic…

Business Insider Latest Story Image
3 mins read

Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …

Business Insider Latest Story Image
2 mins read

Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials

Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …

Business Insider Latest Story Image
1 min read

KTR congratulates Bharat Biotech on Covaxin approval

Hyderabad, Jan 3 (IANS) Telangana Minister for Industry and Information Technology K.T. Rama Rao on…

Business Insider Latest Story Image
2 mins read

Nepal approves Bharat Biotech's Covaxin for emergency use

COVAXIN, which demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical t…

PTI   


Business Insider Latest Story Image
4 mins read

Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1

The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…

Business Insider Latest Story Image
2 mins read

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses

stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…

PTI   


Business Insider Latest Story Image
2 mins read

Avoid Covaxin in case of allergies, fever: Bharat Biotech

Hyderabad, Jan 19 (IANS) Bharat Biotech, makers of India's first indigenous vaccine for Covid-19, h…